ARTICLE | Company News
Santaris, Roche deal
August 11, 2014 7:00 AM UTC
Roche will acquire partner Santaris for $250 million in cash up front and up to $200 million in undisclosed milestones. Santaris is using its locked nucleic acid (LNA) platform to develop antisense dr...